NCI Seeks Answers to Cancer Research Questions
from National Cancer Institute
Two Funding Opportunity Announcements (FOA) have been issued by the National Institutes of Health (NIH) National Cancer Institute (NCI). These announcements include
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)
The purpose of these FOAs is to support new research projects designed to use sound and innovative strategies to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute as the
NCI's Provocative Questions
This program covers two parallel FOAs of identical scientific scope. FOA, RFA-CA-20-004 solicits applications for well-developed research projects using the NIH R01 funding mechanism. The companion FOA, RFA-CA-20-005, is a parallel announcement for exploratory/developmental projects using the NIH R21 mechanism.
To be responsive to these FOAs, each application must specifically address a particular scientific problem identified by a PQ listed in the FOA.
Application deadlines are
April 30, 2020
Nov. 17, 2020
For more information, visit the web pages for FOA,
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063